Location History:
- La Jolla, CA (US) (2021 - 2024)
- San Diego, CA (US) (2024)
Company Filing History:
Years Active: 2021-2024
Title: The Innovative Contributions of Florian Sulzmaier
Introduction
Florian Sulzmaier is a notable inventor based in La Jolla, California, recognized for his significant contributions to the field of biotechnology. With a total of four patents to his name, he has made strides in developing therapeutic solutions for various diseases, particularly in cancer treatment.
Latest Patents
Among his latest patents, Sulzmaier has developed OX40-binding polypeptides and their uses. These innovations include VHH-containing polypeptides that bind OX40, with some embodiments designed to agonize this target. Additionally, he has created binding polypeptides that specifically target PD-1, which are crucial for therapeutic compositions aimed at treating cancer. These include fusion proteins and chimeric antigen receptors, along with pharmaceutical compositions that utilize these polypeptides.
Career Highlights
Throughout his career, Florian Sulzmaier has worked with prominent companies in the biotechnology sector, including Inhibrx, Inc. and Inhibex, Inc. His work has been instrumental in advancing therapeutic strategies that leverage his patented technologies.
Collaborations
Sulzmaier has collaborated with notable professionals in his field, including John C. Timmer and Brendan P. Eckelman. These partnerships have further enhanced the impact of his innovations in biotechnology.
Conclusion
Florian Sulzmaier's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer treatment and therapeutic development.